Arquivos de Asma, Alergia e Imunologia
https://aaai-asbai.org.br/article/doi/10.5935/2526-5393.20220046
Arquivos de Asma, Alergia e Imunologia
Artigo Original

Rinite vasomotora e rinorreia: um possível papel para o efeito anticolinérgico da amitriptilina

Vasomotor rhinitis and rhinorrhea: a possible role for the anticholinergic effect of amitriptyline

Francisco Machado Vieira

Downloads: 0
Views: 70

Resumo

Introdução: A rinite vasomotora (RVM), também denominada idiopática, é um tipo de rinite não alérgica. Pode ser muitas vezes ativada por mudanças de temperatura, especialmente com o ar frio e outras irritantes de vias aéreas. A dosagem de IgE e o citograma nasal são normais, e os testes de inalantes são negativos. A etiologia pode estar associada à desregulação de nervos simpáticos e parassimpáticos da mucosa nasal, onde aumenta a rinorreia e a obstrução nasal. Objetivo: Avaliar a eficácia da amitriptilina no controle da rinorreia vasomotora. Método: Através de estudo retrospectivo, avaliaram-se pacientes com RVM (n = 110), no qual um grupo de n = 12 (11%) apresentava rinorreia profusa há mais de um ano, não controlada, na sua totalidade, com corticosteroide nasal. Usou-se a amitriptilina, um antidepressivo tricíclico, com intensa atividade anticolinérgica com dose de 25 mg/50 mg diária para a rinorreia nesses pacientes. Resultados: Foram avaliados através de uma escala de sintomas (modificada de Wilson AM): 0 = ausente, 1 = leve, bem tolerado, 2 = desconforto interferindo com a concentração, 3 = forte intensidade interferindo no sono e na concentração. Dez pacientes catalogados apresentaram sintomas no grau 3, e dois, no grau 2. A pontuação foi reduzida para grau 0-1 após 4-6 semanas com o uso de amitriptilina por sintomas reflexivos matinais e noturnos. Conclusão: Futuros estudos controlados e com maior número de pacientes seriam necessários para confirmação do efeito farmacológico da amitriptilina na rinorreia da RVM.

Palavras-chave

Rinite vasomotora, amitriptilina, rinorreia.

Abstract

Background: Vasomotor rhinitis (VMR), also referred to as idiopathic rhinitis, is a type of nonallergic rhinitis. It can often be triggered by changes in temperature, especially with cold air and other airway irritants. Immunoglobulin E (IgE) levels and nasal cytograms are normal, and inhalant skin tests are negative. The etiology may be associated with dysregulation of the sympathetic and parasympathetic nervous systems in the nasal mucosa, with increased rhinorrhea and nasal obstruction. Objective: To evaluate the efficacy of amitriptyline in the control of VMR-related rhinorrhea. Method: We retrospectively evaluated 110 patients with VMR, of whom 12 (11%) had profuse rhinorrhea for more than 1 year, not completely controlled with nasal corticosteroids. In these 12 patients, rhinorrhea was treated with amitriptyline, a tricyclic antidepressant with intense anticholinergic activity, at a daily dose of 25 mg/50 mg. Results: Patients were evaluated using a symptom scale (modified from Wilson AM): 0 = absent; 1 = mild, well tolerated; 2 = discomfort interfering with concentration; and 3 = severe intensity interfering with sleep and concentration. Ten patients had grade 3 symptoms, and 2 had grade 2 symptoms. The score decreased to grade 0-1 after 4-6 weeks of amitriptyline use for reflex symptoms in the morning and at night. Conclusion: Further controlled studies with a larger sample size are needed to confirm the pharmacological effect of amitriptyline on VMRrelated rhinorrhea.

Keywords

Vasomotor rhinitis, amitriptyline, rhinorrhea.

Referências

1. Bernstein IL, Li JT, Bernstein DI, Hamilton R, Spector SL, Tan R, et al. Allergy diagnostic testing an updated practice parameter. Ann Allergy Asthma Immunol. 2008;100 (suppl 3):S1-148.

2. Cruz AA, Herrerias de Campos CA, Jacob CMA, Sarinho ESC, Sakano E, Castro FFM. II Consenso Brasileiro sobre Rinites 2006. Rev bras alerg imunopatol. 2006;29:32-58.

3. Leader P, Geiger Z. Vasomotor Rhinitis. [Updated 2022 Jul 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Disponível em: https://www.ncbi.nlm.nih.gov/books/ NBK547704/

4. Dykewicz MS, Wallace DV, Amrol DJ, Baroody FM, Bernstein JA, Craig TJ, et al. Rhinitis 2020: A practice parameter update. J. Allergy Clin Imunol, 2020;146:721-67.

5. Hellings PW, Klimek L, Cingi C, Agache I, Akdis C, Bachert C, et al. Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2017 Nov;72(11):1657‑65. doi: 10.1111/all.13200.

6. Settipane RA. Epidemiology of vasomotor rhinitis. World Allergy Organ J. 2009;2:115-8.

7. Scalupa MD, Kaliner M. Non allergic rhinitis with a focus on vasomotor rhinitis, clinical importance, diferencial diagnosis and effective treatment recomendations. World Allergy Organization Journal. 2009;2:20-5.

8. Pattanaik D, Lieberman D. Vasomotor rhinitis. Current Allergy and Asthma reports. 2010;10:84-91.

9. Gillman PK, Tricyclic antidepressant pharmacology and therapeutic drug interactions up dated. Br J Pharmacol. 2007;151:737-48.

10. Gerven LV, Alpizar YA, Wouters MM, Boeckxstaens G, Talavera K, Hellings PW. Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in petients with idiopathic rhinitis. Rhinitis Sinusitis, and upper airway disease. 2014;133:1332-9.

11. Mygind N, Borum P. Intranasal ipratropium: literature abstracts and comments. Rhinology. 1989; (suppl 9):37-44.

12. Georgitis JW.The anticholinergic treatment of allergic perennial rhinitis. J Allergy Clin Immunol. 1992;90:1071-6.

13. Bernstein JA. Azelastine hydrochloride: A review of pharmacology, pharmacokinetics, clinical efficacy and tolerability. Current Medical and Research and Opinion. 2007;23:2441-52.

14. Beard S. Prim Care: Rinithis. 2014;41:33-46. doi 10.2016/j.pop 2013.10.005.

15. Wilson AM, Dempsey OJ, Sims EJ Lipwort BJ. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma. Clin Exp Allerg. 2001;31(4):616-24.

16. Jacobs R, Lieberman P, Kent E, Silvey M, Locantore N, Philpot E. Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment. Allergy and Asthma Proceedings. 2009;30(2):120-7.


Submetido em:
23/12/2021

Aceito em:
13/07/2022

6a0b6fa9a953951792242df5 aaai Articles
Links & Downloads

Arq Asma Alerg Imunol

Share this page
Page Sections